Scientific Health Development Partners
VC Fund
Dallas, United States
Scientific Health Development Partners is a VC fund in Dallas focused on Health Care and Medical Device. Scientific Health Development ("SHD") is a boutique investment company located in Dallas, TX. SHD invests in early-stage, innovative healthcare-related technologies and products.
- Total investments:
- 16
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Scientific Health Development Partners invests in
Stages Scientific Health Development Partners invests in
Countries Scientific Health Development Partners invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Phil Romano
|
|||
Stuart Fitts
|
|||
3 more contacts available
Investment Focus
Industry
- Health Care 11 (69%)
- Medical Device 6 (38%)
- Medical 5 (31%)
- Biotechnology 3 (19%)
- Women's 1 (6%)
Stage
- Series B 6 (38%)
- Series A 4 (25%)
- Series C 3 (19%)
- Seed 2 (13%)
- Grant 1 (6%)
Country
- United States 10 (63%)
- Israel 1 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Phil Romano
Co-Founder and General Partner
|
Co-Founder and General Partner | Total investments: 0 | Find email | |
|
Stuart Fitts
Co-Founder and General Partner
|
Co-Founder and General Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Urologic Health
|
Urologic Health developing innovative solutions to improve bladder function diagnosis, monitoring, and treatment of urinary disorders. | $11M / Seed / May 14, 2026 | |
Cooler Heads
|
Cooler Heads develops cold caps designed for chemotherapy patients. | $11M / Series A / Jul 22, 2025 | |
SecondWave Systems
|
SecondWave Systems develops an ultrasound stimulation platform that will give patients and their physicians a new option for treating debilitating or life-threatening diseases. Their technology utilizes non-invasive, low-intensity focused ultrasound to modulate nerves, cells, and organs deep within the body. They provide technology that suppressesneural and cellular pathways with the potential to treat many conditions, including inflammation, pain, and a variety of other disorders. | $7M / Series A / Apr 08, 2025 | |
Podimetrics
|
Podimetrics is a care management company with the leading solution to help prevent diabetic foot ulcers (DFU), one of the most debilitating and costly complications of diabetes. On behalf of payers and at-risk providers, we send high-risk patients our FDA-cleared, cellular-connected SmartMat. After placing their feet on the mat for just 20 secondsa day, patients’ data are automatically sent to our care management team that triages any concerning findings. By combining cutting-edge technology with best-in-class care management, Podimetrics earns high engagement rates from patients and allows clinicians to achieve unparalleled outcomes saving limbs, lives, and money. Founded in 2011 by a physician and engineers from MIT and Harvard, Podimetrics is headquartered in Somerville, MA and backed by Norwich Ventures, Scientific Health Development, and Rock Health. For more information, go to www.podimetrics.com or follow us on Twitter @podimetrics. | $45M / Series C / Mar 24, 2022 | |
Koya Medical
|
Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases to increase movement, mobility, and personalized care that is unavailable with traditional compression therapy. | $26M / Series B / Feb 03, 2022 | |
Empirical Spine
|
Empirical Spine is a developer of a medical stabilization system designed to treat degenerative lumbar spinal disorders. The company's system is a minimally invasive flexion-restricting stabilization device that aids patients suffering from spinal stenosis with grade I degenerative spondylolisthesis, enabling hospitals to have tools for securespinal surgeries. | $10M / Series B / Jun 02, 2021 | |
MiNDERA Corporation
|
MiNDERA Dx conducts research and development on non-invasive molecular testing for skin cancer and other skin diseases. The company is currently focused on a technology solution to extract skin biomarkers in a non-invasive manner. It was founded in 2013 and is based in San Francisco, United States. | $12M / Series A / May 12, 2021 | |
|
Koya Medical
|
Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases to increase movement, mobility, and personalized care that is unavailable with traditional compression therapy. | $11M / Series A / Jan 14, 2021 | |
|
Podimetrics
|
Podimetrics is a care management company with the leading solution to help prevent diabetic foot ulcers (DFU), one of the most debilitating and costly complications of diabetes. On behalf of payers and at-risk providers, we send high-risk patients our FDA-cleared, cellular-connected SmartMat. After placing their feet on the mat for just 20 secondsa day, patients’ data are automatically sent to our care management team that triages any concerning findings. By combining cutting-edge technology with best-in-class care management, Podimetrics earns high engagement rates from patients and allows clinicians to achieve unparalleled outcomes saving limbs, lives, and money. Founded in 2011 by a physician and engineers from MIT and Harvard, Podimetrics is headquartered in Somerville, MA and backed by Norwich Ventures, Scientific Health Development, and Rock Health. For more information, go to www.podimetrics.com or follow us on Twitter @podimetrics. | $13.4M / Series B / May 09, 2019 | |
Channel Medsystems
|
Channel Medystems is a clinical-stage medical technology engaged in the development of proprietary cryo-ablation delivery technologies. The company is developing proprietary cryo-ablation delivery technologies. They strive to develop treatments to meet the unique needs of female patients and the high standards of their healthcare providers.Channel Medsystems was founded in 2009 and headquartered in San Francisco, California. | $14.1M / Series C / Aug 23, 2017 | |
| See all 16 investments → | |||
Co-Investors
Arboretum Ventures
2 deals together
D1 Capital Partners
2 deals together
Easton Capital
2 deals together
Koa Labs
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Scientific Health Development Partners invest in?
Scientific Health Development Partners invests primarily in Health Care, Medical Device and Medical startups, most often at Series B and Series A stage. Most of the 16 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Scientific Health Development Partners?
Public channels for Scientific Health Development Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Scientific Health Development Partners?
The team at Scientific Health Development Partners includes Phil Romano (Co-Founder and General Partner) and Stuart Fitts (Co-Founder and General Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
